Whole Slide Imaging Market Size (2024 - 2029)

The Whole Slide Imaging market is projected to experience significant growth over the forecast period, driven by advancements in technology and an increase in research and development activities. The market's expansion is further supported by the rising adoption of virtual slides and the growing incidence of cancer, which necessitates advanced image analysis for rapid diagnosis. The COVID-19 pandemic accelerated the implementation of whole slide imaging in laboratories, contributing to its market growth. Despite challenges such as stringent regulatory requirements and high costs, the market is expected to benefit from strategic initiatives by key players and the increasing use of whole slide imaging in chronic disease research.

Market Size of Whole Slide Imaging Industry

Whole Slide Imaging Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.21 Billion
Market Size (2029) USD 1.65 Billion
CAGR (2024 - 2029) 6.39 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Whole Slide Imaging Market Analysis

The Whole Slide Imaging Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.65 billion by 2029, growing at a CAGR of 6.39% during the forecast period (2024-2029).

COVID-19 significantly impacted the global whole slide imaging market due to the increased research studies conducted to identify COVID-19 strains using whole slide imaging (WSI). For instance, in an article published in March 2023 in PubMed, the Centers for Medicare & Medicaid Services waived the requirement for pathologists to perform diagnostic tests in Clinical Laboratory Improvement Amendments (CLIA)-licensed facilities during the pandemic, which led to the rapid implementation of WSI across all surgical pathology subspecialties in the United States. Thus, the increased demand and implementation of WSI in laboratories significantly impacted the market's growth during the pandemic. In the coming years, the market is expected to witness healthy growth owing to the advancements in whole slide imaging and the rise in research and development utilizing whole slide imaging techniques.

The key factors propelling the whole slide imaging (WSI) market are an increase in research and development in drug discovery processes, technological advancements in whole slide imaging, and the rising popularity of virtual slides compared to physical slides.

Also, the increasing incidence of cancer is expected to drive the growth of the overall market since advanced image analysis can lead to automated examination of histopathology images, which is essential for fast cancer diagnosis. For instance, according to the American Cancer Society 2023 Cancer Statistics, the estimated new number of cancer cases is 1.9 million in the United States in 2023. This estimation includes 1.01 million males and 948,000 cases of females. A significant burden of cancer cases can increase the demand for WSI since WSI scans assist doctors in analyzing larger areas to detect malignant cells or other mutations in a specific tissue, which is further expected to fuel the market growth over the study period.

Furthermore, an increase in research activities and the presence of key players and their strategic activities are expected to bolster the market growth over the study period. For instance, in March 2023, OptraSCAN, an end-to-end digital pathology solution provider, launched the OnDemand Digital Pathology solution that offers complete digital transformation of pathology laboratories in North America. Similarly, using whole slide imaging in various chronic diseases is expected to raise the demand for WSI and bolster market growth. For instance, according to an article published in June 2022 in PubMed, whole slide imaging-based systems were helpful in digitally frozen sections at cancer centers.

Thus, owing to the high number of chronic diseases, an increase in the adoption of WSI in malignant tissue detection and strategic product launches by the key players are expected to bolster the market growth over the study period. However, stringent regulatory approvals and the high cost of whole slide imaging systems are expected to hinder market growth.

Whole Slide Imaging Industry Segmentation

As per the scope of the report, whole slide imaging is a technology where glass slides are scanned to produce digital images. It refers to the scanning of conventional glass slides in order to produce digital slides and is the most recent imaging modality being employed by pathology departments worldwide. The whole slide imaging market is segmented by technology (scanners, IT infrastructure, viewer, and image management system), application (telepathology, cytopathology, immunohistochemistry, and hematopathology), end user (academic institute, research, and other end users), and geography(North America, Europe, Asia-Pacific, Middle East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.

By Technology
Scanners
IT Infrastructure
Viewer
Image Management System
By Application
Telepathology
Cytopathology
Immunohistochemistry
Hematopathology
By End User
Academic Institute
Research
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Whole Slide Imaging Market Size Summary

The whole slide imaging market is poised for substantial growth over the forecast period, driven by technological advancements and increased adoption in various medical and research applications. The market's expansion is fueled by the rising incidence of cancer, which necessitates advanced imaging techniques for rapid diagnosis and treatment planning. The COVID-19 pandemic acted as a catalyst for the adoption of whole slide imaging, as it facilitated research into the virus and led to regulatory changes that accelerated its implementation across surgical pathology subspecialties. The growing popularity of virtual slides over traditional physical slides, coupled with the surge in research and development activities in drug discovery, further propels the market forward. Key players in the industry are actively engaging in strategic collaborations and product launches to enhance their offerings and capture a larger market share.

North America is expected to be a significant contributor to the market's growth, supported by increased investments in drug discovery and development, as well as strategic product launches by major players. The region benefits from government funding and guidelines that promote the use of whole slide imaging in toxicological studies, enhancing the quality and adoption of these systems. The telepathology segment is also witnessing notable growth due to its ability to provide remote consultations and expert opinions, which is particularly valuable in areas lacking specialized pathologists. Despite challenges such as stringent regulatory approvals and high costs, the market is set to expand, driven by the demand for digital pathology solutions and the ongoing development of innovative imaging technologies.

Explore More

Whole Slide Imaging Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Popularity of Virtual Slides as Compared to Physical Slides

      2. 1.2.2 Technological Advancements in Whole Slide Imaging

      3. 1.2.3 Increasing Research in Drug Discovery

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Approvals

      2. 1.3.2 High Cost of Whole Slide Imaging Systems

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Technology

      1. 2.1.1 Scanners

      2. 2.1.2 IT Infrastructure

      3. 2.1.3 Viewer

      4. 2.1.4 Image Management System

    2. 2.2 By Application

      1. 2.2.1 Telepathology

      2. 2.2.2 Cytopathology

      3. 2.2.3 Immunohistochemistry

      4. 2.2.4 Hematopathology

    3. 2.3 By End User

      1. 2.3.1 Academic Institute

      2. 2.3.2 Research

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Whole Slide Imaging Market Size FAQs

The Whole Slide Imaging Market size is expected to reach USD 1.21 billion in 2024 and grow at a CAGR of 6.39% to reach USD 1.65 billion by 2029.

In 2024, the Whole Slide Imaging Market size is expected to reach USD 1.21 billion.

Whole Slide Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)